Skip to main content
. 2017 Mar 3;8(31):50930–50940. doi: 10.18632/oncotarget.15871

Figure 1. Distribution of predicted deleterious mutations in the FANCM gene in ovarian cancer cases and controls with respect to both the translated protein and the exonic architecture of the coding sequence.

Figure 1

Black lines indicate mutations identified in cases only; blue lines indicate mutations detected both cases and controls. No mutations were identified in controls only. Where a mutation was identified in more than one subject, the number of times the mutation was detected is given in brackets.